Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Preferred Stock Liabilities (2020 - 2021)

Celularity (CELU) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $184.2 million as the latest value for Q2 2021.

  • On a quarterly basis, Preferred Stock Liabilities rose 145.66% to $184.2 million in Q2 2021 year-over-year; TTM through Jun 2021 was $184.2 million, a 145.66% increase, with the full-year FY2020 number at $75.0 million, changed N/A from a year prior.
  • Preferred Stock Liabilities was $184.2 million for Q2 2021 at Celularity, up from $75.0 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $184.2 million in Q2 2021 to a low of $75.0 million in Q1 2020.